Edition:
India

MEDNAX Inc (MD.N)

MD.N on New York Stock Exchange

35.90USD
22 Jan 2019
Change (% chg)

$-0.89 (-2.42%)
Prev Close
$36.79
Open
$36.60
Day's High
$36.60
Day's Low
$35.74
Volume
292,412
Avg. Vol
302,389
52-wk High
$62.75
52-wk Low
$31.68

Latest Key Developments (Source: Significant Developments)

Mednax Announces Completion Of $250 Mln Share Repurchase Program
Friday, 14 Dec 2018 

Dec 14 (Reuters) - MEDNAX Inc ::MEDNAX ANNOUNCES COMPLETION OF $250 MILLION ACCELERATED SHARE REPURCHASE PROGRAM.MEDNAX INC - AS OF DECEMBER 13, 2018, APPROXIMATELY $250 MILLION WAS REMAINING UNDER PREVIOUS AUTHORIZATION..  Full Article

Mednax Radiology Solutions Launches Artificial Intelligence Incubator
Tuesday, 27 Nov 2018 

Nov 27 (Reuters) - MEDNAX Inc ::MEDNAX RADIOLOGY SOLUTIONS LAUNCHES ARTIFICIAL INTELLIGENCE INCUBATOR.  Full Article

Mednax Announces Pricing Of $500 Mln Of Senior Notes
Thursday, 8 Nov 2018 

Nov 7 (Reuters) - MEDNAX Inc ::MEDNAX ANNOUNCES PRICING OF $500 MILLION OF 6.250% SENIOR NOTES DUE 2027.PRICING OF $500 MILLION AGGREGATE PRINCIPAL AMOUNT OF ITS 6.250% SENIOR NOTES DUE JANUARY 15, 2027.  Full Article

Mednax launches private offering of $750 mln senior notes due 2026
Wednesday, 7 Nov 2018 

Nov 7 (Reuters) - MEDNAX Inc ::MEDNAX LAUNCHES PRIVATE OFFERING OF $750 MILLION SENIOR NOTES DUE 2026.MEDNAX INC - INTENDS TO USE PROCEEDS TO REPAY A PORTION OF INDEBTEDNESS OUTSTANDING UNDER ITS SENIOR UNSECURED REVOLVING CREDIT FACILITY.  Full Article

Mednax Reports Third Quarter 2018 Results
Thursday, 1 Nov 2018 

Nov 1 (Reuters) - MEDNAX Inc ::MEDNAX REPORTS THIRD QUARTER GAAP EPS OF $0.72; ADJUSTED EPS OF $0.94.SEES Q4 2018 ADJUSTED EARNINGS PER SHARE $0.87 TO $0.95.SEES Q4 2018 EARNINGS PER SHARE $0.65 TO $0.73.Q3 ADJUSTED EARNINGS PER SHARE $0.94.Q3 EARNINGS PER SHARE $0.72.Q3 REVENUE $897 MILLION VERSUS I/B/E/S VIEW $908 MILLION.Q3 SAME STORE SALES ROSE 1.2 PERCENT.Q3 EARNINGS PER SHARE VIEW $0.96 -- THOMSON REUTERS I/B/E/S.ANNOUNCES INITIATION OF PROCESS TO SELL MEDDATA.IS INITIATING A PROCESS TO POTENTIALLY SELL MEDDATA, COMPANY'S MANAGEMENT-SERVICES ORGANIZATION.MEDNAX - CURRENTLY INTENDS TO USE PROCEEDS FROM A POTENTIAL TRANSACTION FOR MEDDATA TO FUND SHARE REPURCHASES, DEBT REPAYMENT, AND FUTURE ACQUISITIONS.TOTAL SAME-UNIT REVENUE GROWTH FOR THREE MONTHS ENDING DECEMBER 31, 2018 WILL BE IN A RANGE OF FLAT TO TWO PERCENT.  Full Article

Mednax Announces Acquisition Of Leading Tennessee Radiology Practice
Thursday, 1 Nov 2018 

Nov 1 (Reuters) - MEDNAX Inc ::MEDNAX ANNOUNCES ACQUISITION OF LEADING TENNESSEE RADIOLOGY PRACTICE.MEDNAX INC - NO ADDITIONAL TERMS OF TRANSACTION WERE DISCLOSED..MEDNAX INC - WAS A CASH TRANSACTION AND IT IS EXPECTED TO BE IMMEDIATELY ACCRETIVE TO EARNINGS.MEDNAX INC - EIGHT PHYSICIAN GROUP PRACTICES HAVE BECOME PART OF MEDNAX IN 2018.MEDNAX INC - BUYS ASSOCIATES IN DIAGNOSTIC RADIOLOGY, P.C..  Full Article

Mednax Appoints Stephen Farber As Executive Vice President, To Succeed CFO
Thursday, 23 Aug 2018 

Aug 23 (Reuters) - MEDNAX Inc ::MEDNAX APPOINTS STEPHEN D. FARBER AS EXECUTIVE VICE PRESIDENT, TO SUCCEED CHIEF FINANCIAL OFFICER.MEDNAX INC - APPOINTMENT OF STEPHEN D. FARBER AS EXECUTIVE VICE PRESIDENT, EFFECTIVE AUGUST 27, 2018.MEDNAX INC - FARBER WILL ASSUME ADDITIONAL ROLE OF CHIEF FINANCIAL OFFICER IN NOVEMBER 2018.MEDNAX INC - FARBER TO SUCCEED VIVIAN LOPEZ-BLANCO, WHO RECENTLY ANNOUNCED HER PLANNED RETIREMENT FROM COMPANY.  Full Article

Mednax Reports Second Quarter GAAP EPS Of $0.85 Adjusted EPS Of $1.07
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - MEDNAX Inc ::MEDNAX REPORTS SECOND QUARTER GAAP EPS OF $0.85; ADJUSTED EPS OF $1.07.SEES Q3 2018 ADJUSTED EARNINGS PER SHARE $0.94 TO $0.99.SEES Q3 2018 EARNINGS PER SHARE $0.72 TO $0.77.Q2 ADJUSTED EARNINGS PER SHARE $1.07.Q2 EARNINGS PER SHARE $0.85.Q2 REVENUE $916 MILLION VERSUS I/B/E/S VIEW $912.4 MILLION.Q2 SAME STORE SALES ROSE 3.2 PERCENT.BOARD AUTHORIZES SHARE REPURCHASE OF UP TO $500 MILLION.Q2 EARNINGS PER SHARE VIEW $1.06 -- THOMSON REUTERS I/B/E/S.VIVIAN LOPEZ-BLANCO HAS INFORMED MEDNAX OF HER INTENT TO RETIRE AS CHIEF FINANCIAL OFFICER OF THE COMPANY.MEDNAX - TO CONDUCT A FORMAL SEARCH FOR A SUCCESSOR, LOPEZ-BLANCO WILL REMAIN THROUGHOUT THE SEARCH PROCESS AND FOR A TRANSITIONAL PERIOD THEREAFTER.FOR Q3 2018, EXPECTS EBITDA GROWTH BETWEEN THREE PERCENT AND EIGHT PERCENT LOWER, COMPARED TO THE PRIOR-YEAR PERIOD EBITDA OF $151.5 MILLION.  Full Article

Court Rejects Mednax's Request To Stop Atrium Health's Transition To Scope Anesthesia
Monday, 25 Jun 2018 

June 25 (Reuters) - Atrium Health::ATRIUM HEALTH - COURT REJECTED MEDNAX'S REQUEST FOR PRELIMINARY INJUNCTION STOPPING CO'S TRANSITION TO SCOPE ANESTHESIA, ON JULY 1.  Full Article

Mednax Inc Reports Adjusted EPS Of $0.89
Tuesday, 1 May 2018 

May 1 (Reuters) - MEDNAX Inc ::REPORTS ADJUSTED EPS OF $0.89.QTRLY EARNINGS PER SHARE $0.68.MEDNAX'S NET REVENUE FOR THREE MONTHS ENDED MARCH 31, 2018 INCREASED BY 7.9 PERCENT, TO $901.9 MILLION.SAME-UNIT REVENUE FROM NET REIMBURSEMENT-RELATED FACTORS INCREASED BY 2.1 PERCENT FOR 2018 Q1.FOR 2018 Q2, EXPECTS EARNINGS PER SHARE WILL BE IN A RANGE OF $0.81 TO $0.86 PER DILUTED SHARE.FOR 2018 Q2 EXPECTS ADJUSTED EPS WILL BE IN A RANGE OF $1.04 TO $1.09.FOR 2018 Q2, MEDNAX EXPECTS THAT EBITDA GROWTH WILL BE BETWEEN ONE PERCENT AND SIX PERCENT.OUTLOOK ASSUMES TOTAL SAME-UNIT REVENUE GROWTH FOR THREE MONTHS ENDED JUNE 30, 2018 WILL BE IN A RANGE OF TWO TO FOUR PERCENT.Q1 EARNINGS PER SHARE VIEW $0.86, REVENUE VIEW $903.6 MILLION -- THOMSON REUTERS I/B/E/S.Q2 EARNINGS PER SHARE VIEW $1.07 -- THOMSON REUTERS I/B/E/S.  Full Article